Views: 0 Author: Site Editor Publish Time: 2024-05-14 Origin: Site
Inquire
Welcome to visit us at Shanghai&Milan CPHI in 2024!
Sichuan Pukang Pharmaceutical Phase II Facility Commissioned, Expanding Manufacturing Capacity for Long-Acting Peptide Raw Materials
Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET